In clinical trials, tirzepatide helped participants lose an average of 15% to 22% of their body weight over 72 weeks, depending on the dose used
Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing
Do ferroptosis modulators synergize with standard preventive measures (e.g., hydration) or pose risks of off-target effects
GLP-1 Alternatives to Mounjaro (tirzepatide) As mentioned, GLP-1 treatments mimic a natural hormone in your gut, helping control your appetite and making you feel fuller for longer
Among patients who underwent biopsy, the response rate rose to 75%, with nearly 30% achieving near-complete disease reversal
Without an on-label indication for T1D, GLP-1s remain costly and out of reach for most